Enantioselective total synthesis of the natural γ -tocopherol metabolite (S)-γ-CEHC (S)-LLU-α

Organic Letters

Volumn 12, Issue 3, 2010, Pages 580-583

  Lecea, Mercedes ^a,c   Hernández Torres, Gloria ^a   Urbano, Antonio ^a   Carreño, M Carmen ^a   Coloberť, Françoise ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,7,8 TRIMETHYL 2 (BETA CARBOXYETHYL) 6 HYDROXYCHROMAN; 2,7,8-TRIMETHYL-2-(BETA-CARBOXYETHYL)-6-HYDROXYCHROMAN; CHROMAN DERIVATIVE; GAMMA TOCOPHEROL; PROPIONIC ACID DERIVATIVE;

ANIMAL; ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; RAT; STEREOISOMERISM; SYNTHESIS;

ANIMALS; CATALYSIS; CHROMANS; GAMMA-TOCOPHEROL; MOLECULAR STRUCTURE; PROPIONIC ACIDS; RATS; STEREOISOMERISM;

EID: 75749095138     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol9027804     Document Type: Article

References (35)

1. Murray, E. D., Jr.; Kantoci, D.; DeWind, S. A.; Bigornia, A. E.; D'Amico, D. C.; King, J. G., Jr.; Pham, T.; Levine, B. H.; Jung, M. E.; Wechter, W. J. Life Sci. 1995, 57, 2145-2161.
2. Wechter, W. L.; Kantoci, D.; Murray, E. D., Jr.; D'Amico, D. C.; Jung, M. E.; Wang, W.-H. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 6002-6007.
3. Kantoci, D.; Wechter, W. J.; Murray, E. D., Jr.; Dewind, S. A.; Borchardt, D.; Khan, S. I. J. Pharm. Exp. Ther. 1997, 282, 648-656.
4. Murray, E. D., Jr.; Wechter, W. J.; Kantoci, D.; Wang, W.-H.; Pharm, T.; Quiggle, D. D.; Gibson, K. M.; Leipold, D.; Anner, B. M. J. Pharm. Exp. Ther. 1997, 282, 657-662.
5. Hattori, A.; Fukushima, T.; Yoshimura, H.; Abe, K.; Imai, K. Biol. Pharm. Bull. 2000, 23, 1395-1397.
6. Lodge, J. K.; Ridington, J.; Leonard, S.; Vaule, H.; Traber, M. G. Lipids 2001, 36, 43-48.
7. (a) Yoshida, Y.; Niki, E. Biofactors 2002, 16, 93-103.
8. (b) BetancorFernandez, A.; Sies, H.; Stahl, W.; Polidori, M. C. Free Radical Res. 2002, 36, 915-921.
9. Review: Odinokov, V. N.; Spivak, A. Y.; Knyshenko, O. V. Russ. J. Bioorg. Chem. 2007, 33, 359-375.
10. Hensley, K.; Benaksas, E. J.; Bolli, R.; Comp, R.; Grammas, P.; Hamdheydari, L.; Mou, S.; Pye, Q. N.; Stoddard, M. F.; Wallis, G.; Williamson, K. S.; West, M.; Wechter, W. J.; Floyd, R. A. Free Radical Biol. Med. 2004, 56, 1-15.
11. (a) Appenroth, D.; Karge, E.; Kieâling, G.; Wecther, W. J.; Winnefeld, K.; Fleck, C. Toxicol. Lett. 2001, 122, 255-265.
12. (b) Takata, J.; Hidaka, R.; Yamasaki, A.; Hattori, A.; Fukushima, T.; Tanabe, M.; Matsunaga, K.; Karube, Y.; Imai, K. J. Lipid Res. 2002, 43, 2196-2204.
13. (a) Jiang, Q.; Elson-Schwab, I.; Courtemanche, C.; Ames, B. N. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 11494-11499.
14. (b) Grammas, P.; Hamdheydari, L.; Benaksas, E. J.; Mou, S.; Pye, Q. N.; Wechter, W. J.; Floyd, R. A.; Stewart, C.; Hensley, K. Res. Commun. 2004, 319, 1047-1052.
15. Review: Shen, H. C. Tetrahedron 2009, 65, 3931-3952.
16. Sachdeva, R.; Thomas, B.; Wang, X.; Ma, J.; Jones, K. H.; Hatcher, P. G.; Cornwell, D. G. Chem. Res. Toxicol. 2005, 18, 1018-1025.
17. Jung, M. E.; MacDougall, J. M. Tetrahedron Lett. 1999, 40, 6339-6342.
18. (a) Hernández-Torres, G.; Urbano, A.; Carreño, M. C.; Colobert, F. Org. Lett. 2009, 11, 4930-4933.
19. (b) Carreño, M. C.; Hernández-Torres, G.; Urbano, A.; Colobert, F. Eur. J. Org. Chem. 2008, 2035-2038.
20. Review: Carreño, M. C.; Hernández-Torres, G.; Ribagorda, M.; Urbano, A. Chem. Commun. 2009, 6129-6144.
21. (a) Hoefnagel, A. J.; Gunnewegh, E. A.; Downing, R. S.; Van Bekkum, H. J. Chem. Soc., Chem. Commun. 1995, 225-226.
22. (b) Graham, S. R.; Murphy, J. A.; Kennedy, A. R. J. Chem. Soc., Perkin Trans. 1 1999, 21, 3071-3073.
23. (c) Posakony, J.; Hirao, M.; Stevens, S.; Simon, J. A.; Bedalov, A. J. Med. Chem. 2004, 47, 2635-2644.
24. Solladié, G.; Hutt, J.; Girardin, A. Synthesis 1987, 173-175.
25. Li, X.; Ohtake, H.; Takahashi, H.; Ikegami, S. Tetrahedron 2001, 57, 4297-4309.
26. Cohen, N.; Schaer, B.; Saucy, G.; Borer, R.; Todaro, L.; Chiu, A.M. J. Org. Chem. 1989, 54, 3282-3292.
27. When the reaction was carried out with the OAc-protected analogue of (SS)-3, we observed a 37:63 diastereoisomeric ratio, indicating a remarkable effect of the remote protecting group in the selectivity of the process.
28. CCDC-742661 for (SS,S)-12 contains the supplementary crystallography data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/datajequest/cif.
29. (a) Mannam, S.; Sekar, G. Tetrahedron Lett. 2008, 49, 2457-2460.
30. (b) Carlsen, P. H. J.; Katsuki, T.; Martin, V. S.; Sharpless, K. B. J. Org. Chem. 1981, 46, 3936-3938.
31. (c) Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P. Synthesis 1994, 639-666.
32. (d) Grill, J. M.; Ogle, J. W.; Miller, S. A. J. Org. Chem. 2006, 71, 9291-9296.
33. (e) Zhao, M.; Li, J.; Song, Z.; Desmond, R.; Tschaen, D. M.; Grabowski, E. J. J.; Reider, P. J. Tetrahedron Lett. 1998, 39, 5323-5326.
34. Kraus, G. A.; Roth, B. J. Org. Chem. 1980, 45, 4825-4830.
35. R(2S) = 28.8 min.